Blood Group Typing Market

Blood Group Typing Market (Product: Instruments, Consumables, and Services; and Technique: PCR-based, Microarray-based, and Assay-based, and Massively Parallel) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Blood Group Typing Market Outlook 2031

  • The global industry was valued at US$ 2.6 Bn in 2022
  • It is estimated to grow at a CAGR of 8.8% from 2023 to 2031 and reach US$ 5.5 Bn by the end of 2031

Analyst Viewpoint

Increase in cases of road accidents and rise in prevalence of infectious disorders are fueling the blood group typing market development.

Blood typing is an indispensable technique for ascertaining an individual's blood characteristics. Surge in trauma cases needing blood transfusions and growth in demand for grouping of blood during pregnancy are boosting the blood group typing industry demand.

Key players are concentrating on creating new products and solutions for molecular blood group typing analysis. They are also offering products that facilitate effective management of the workload associated with blood testing.

Market Introduction

Blood typing is an indispensable technique for identifying an individual's blood characteristics to ensure the safety of blood donation and transfusion procedures. Blood group determination helps in understating a person's blood group and determining the presence of Rh factor in red blood cells.

ABO and Rh blood typing procedures are used to determine an individual's blood type, which is essential for safe blood transfusions. The presence or lack of specific proteins on red blood cells-known as antigens that shape a person's blood group-determines the blood type, which is inherited from their parents.

Four main blood types may be distinguished using the ABO blood typing system: Type A, Type B, Type AB, and Type O. Every blood type is important since it affects compatibility for blood transfusions and advances the knowledge of each person's physiological makeup.

Attribute Detail
Drivers
  • Increase in Cases of Road Accidents
  • Rise in Prevalence of Infectious Disorders

Increase in Cases of Road Accidents Augmenting Blood Group Typing Market Size

Blood group typing is performed to safely give or receive blood, additionally, blood transfusion is also done to check the presence of Rh factor on the surface of red blood cells. Blood typing products are in high demand due to the increase in traffic accidents.

In October 2021, the German Federal Statistics Office (Destatis) reported that 5,131 persons in Germany lost their lives in traffic accidents in 2020. Furthermore, a study published by the World Health Organization in 2020 stated that nearly 1.5 million people die each year due to road traffic injuries.

Growth in demand for blood group typing in prenatal testing and increase in use of blood group typing in forensic sciences are contributing to the blood group typing market growth.

Rise in Prevalence of Infectious Disorders Propelling Market Development

Pathogens that enter the body, proliferate, and have the potential to cause an infection include bacteria, viruses, fungi, and parasites. Blood group typing is frequently used to check for a particular antibody produced by infectious agents, which helps doctors treat infectious diseases and stop patients from getting sicker and spreading the disease to other people.

The World Health Organization (WHO), in October 2022, stated that roughly 1.6 million people worldwide died from tuberculosis in 2021 (including 187,000 people with HIV).

Furthermore, according to the same source, the prevalence of anemia in children is 48.2% in 2021 and 12.8% in adults. This number is predicted to increase globally in the years to come.As a result, growth in prevalence of blood disorders is propelling the blood group typing market expansion.

Regional Outlook

Attribute Detail
Leading Region North America

North America held the largest market share in 2022, according to the latest blood group typing market analysis. Increase in number of road accidents, rise in prevalence of chronic diseases, and surge in demand for blood transfusion are fueling the market dynamics of the region.

In 2022, the Association for Safe International Road Travel stated that the U.S. is one of the busiest countries in terms of road traffic with nearly 284 million vehicles in operation as of the third quarter of 2021. As of 2020, there were about 228.7 million drivers with valid driver's licenses.

Heavy road traffic is contributing to the rise in traffic accidents. Approximately 12.15 million vehicles were engaged in crashes in the U.S. as of September 2020, with passenger automobiles accounting for more than half of the total. Thus, increase in traffic fatalities and collisions is bolstering the blood group typing market share.

Analysis of Key Players

The global blood group typing landscape is highly competitive, with several opportunities for expansion and innovation. Companies operating in the blood group typing industry are adopting various strategies, such as mergers and acquisitions and new product development, to support medical research and improve patient care.

In February 2022, InTec, an IVD company specializing in infectious disease diagnostics with a focus on screening at the point of care, announced the availability of a newly redesigned ABO & RhD Blood Grouping Kit (Solid-phase method) for blood typing and screening.

Grifols, S.A., Bio-Rad Laboratories, Inc., Merck KGaA, Ortho Clinical Diagnostics, AliveDX, ABG Health Care GmbH, Immucor, Inc., Danaher Corporation, Agena Bioscience, Inc., Rapid Labs Ltd., and Novacyt Group are some of the key players in the global blood group typing market.

Each of these companies has been profiled in the blood group typing market report based on parameters such as company overview, business strategies, financial overview, business segments, product portfolio, and recent developments.

Key Developments in Blood Group Typing Market

  • In March 2023, Werfen completed the acquisition of Immucor, Inc. after obtaining all necessary regulatory and antitrust approvals. Immucor is a privately held, US-based company in the in vitro diagnostics (IVD) sector, with a solid global presence in the transfusion and transplant markets.
  • In April 2022, Grifols announced the completion of the acquisition of Biotest AG, a European healthcare company specializing in innovative hematology and clinical immunology

Blood Group Typing Market Snapshot

Attribute Detail
Market Size in 2022 US$ 2.6 Bn
Market Forecast (Value) in 2031 US$ 5.5 Bn
Growth Rate (CAGR) 8.8%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Tons US$ Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy and recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Product
    • Instruments
      • Automated
      • Semi-automated
      • Manual
    • Consumables
      • Reagents
      • Test Kits
      • Antisera
      • Others
    • Services
  • Technique
    • PCR-based
    • Microarray-based
    • Assay-based
    • Massively Parallel
  • Test
    • Antibody Screening
    • HLA Typing
    • ABO Matching Test
    • Cross Matching Test
    • Antigen Typing
  • End-user
    • Hospitals
    • Clinical Laboratories
    • Blood Banks
    • Others
Regions Covered
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa
Companies Profiled
  • Grifols, S.A.
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Ortho Clinical Diagnostics
  • AliveDx
  • ABG Health Care GmbH
  • Immucor, Inc.
  • Danaher Corporation
  • Agena Bioscience, Inc.
  • Rapid Labs Ltd.
  • Novacyt Group
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global blood group typing market in 2022?

It was valued at US$ 2.6 Bn in 2022

How is the blood group typing business expected to grow by 2031?

It is projected to grow at a CAGR of 8.8% during the forecast period

What are the key factors driving the demand for blood group typing?

Increase in cases of road accidents and rise in prevalence of infectious disorders

Which was the major region in the blood group typing landscape in 2022?

North America was the leading region in 2022

Who are the key blood group typing product manufacturers?

Grifols, S.A., Bio-Rad Laboratories, Inc., Merck KGaA, Ortho Clinical Diagnostics, AliveDX, ABG Health Care GmbH, Immucor, Inc., Danaher Corporation, Agena Bioscience, Inc., Rapid Labs Ltd., and Novacyt Group

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Blood Group Typing Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Blood Group Typing Market Analysis and Forecast, 2017–2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Key Product/Brand Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Blood Group Typing Market Analysis and Forecast, by Product

        6.1. Introduction and Definitions

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Product, 2017–2031

            6.3.1. Instruments

                6.3.1.1. Automated

                6.3.1.2. Semi-automated

                6.3.1.3. Manual

            6.3.2. Consumables

                6.3.2.1. Reagents

                6.3.2.2. Test Kits

                6.3.2.3. Antisera

                6.3.2.4. Others

            6.3.3. Services

        6.4. Market Attractiveness, by Product

    7. Global Blood Group Typing Market Analysis and Forecast, by Technique

        7.1. Introduction and Definitions

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Technique, 2017–2031

            7.3.1. PCR-based

            7.3.2. Microarray-based

            7.3.3. Assay-based

            7.3.4. Massively Parallel

            7.3.5. 7.4 Market Attractiveness, by Technique

    8. Global Blood Group Typing Market Analysis and Forecast, by Test

        8.1. Introduction and Definitions

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by Test, 2017–2031

            8.3.1. Antibody Screening

            8.3.2. HLA Typing

            8.3.3. ABO Matching Test

            8.3.4. Cross Matching Test

            8.3.5. Antigen Typing

        8.4. Market Attractiveness, by Test

    9. Global Blood Group Typing Market Analysis and Forecast, by End-user

        9.1. Introduction and Definitions

        9.2. Key Findings/Developments

        9.3. Market Value Forecast, by End-user, 2017–2031

            9.3.1. Hospitals

            9.3.2. Clinical Laboratories

            9.3.3. Blood Banks

            9.3.4. Others

        9.4. Market Attractiveness, by End-user

    10. Global Blood Group Typing Market Analysis and Forecast, by Region

        10.1. Key Findings

        10.2. Market Value Forecast, by Region, 2017–2031

            10.2.1. North America

            10.2.2. Europe

            10.2.3. Asia Pacific

            10.2.4. Latin America

            10.2.5. Middle East & Africa

        10.3. Market Attractiveness, by Region

    11. North America Blood Group Typing Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product, 2017–2031

            11.2.1. Instruments

                11.2.1.1. Automated

                11.2.1.2. Semi-automated

                11.2.1.3. Manual

            11.2.2. Consumables

                11.2.2.1. Reagents

                11.2.2.2. Test Kits

                11.2.2.3. Antisera

                11.2.2.4. Others

            11.2.3. Services

        11.3. Market Attractiveness, by Product

        11.4. Market Value Forecast, by Technique, 2017–2031

            11.4.1. PCR-based

            11.4.2. Microarray-based

            11.4.3. Assay-based

            11.4.4. Massively Parallel

        11.5. Market Attractiveness, by Technique

        11.6. Market Value Forecast, by Test, 2017–2031

            11.6.1. Antibody Screening

            11.6.2. HLA Typing

            11.6.3. ABO Matching Test

            11.6.4. Cross Matching Test

            11.6.5. Antigen Typing

        11.7. Market Attractiveness, by Test

        11.8. Market Value Forecast, by End-user, 2017–2031

            11.8.1. Hospitals

            11.8.2. Clinical Laboratories

            11.8.3. Blood Banks

            11.8.4. Others

        11.9. Market Attractiveness, by End-user

        11.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.10.1. U.S.

            11.10.2. Canada

        11.11. Market Attractiveness Analysis

            11.11.1. By Product

            11.11.2. By Technique

            11.11.3. By Test

            11.11.4. By End-user

            11.11.5. By Country

    12. Europe Blood Group Typing Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product, 2017–2031

            12.2.1. Instruments

                12.2.1.1. Automated

                12.2.1.2. Semi-automated

                12.2.1.3. Manual

            12.2.2. Consumables

                12.2.2.1. Reagents

                12.2.2.2. Test Kits

                12.2.2.3. Antisera

                12.2.2.4. Others

            12.2.3. Services

        12.3. Market Attractiveness, by Product

        12.4. Market Value Forecast, by Technique, 2017–2031

            12.4.1. PCR-based

            12.4.2. Microarray-based

            12.4.3. Assay-based

            12.4.4. Massively Parallel

        12.5. Market Attractiveness, by Technique

        12.6. Market Value Forecast, by Test, 2017–2031

            12.6.1. Antibody Screening

            12.6.2. HLA Typing

            12.6.3. ABO Matching Test

            12.6.4. Cross Matching Test

            12.6.5. Antigen Typing

        12.7. Market Attractiveness, by Test

        12.8. Market Value Forecast, by End-user, 2017–2031

            12.8.1. Hospitals

            12.8.2. Clinical Laboratories

            12.8.3. Blood Banks

            12.8.4. Others

        12.9. Market Attractiveness, by End-user

        12.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.10.1. Germany

            12.10.2. U.K.

            12.10.3. France

            12.10.4. Italy

            12.10.5. Spain

            12.10.6. Rest of Europe

        12.11. Market Attractiveness Analysis

            12.11.1. By Product

            12.11.2. By Technique

            12.11.3. By Test

            12.11.4. By End-user

            12.11.5. By Country/Sub-region

    13. Asia Pacific Blood Group Typing Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product, 2017–2031

            13.2.1. Instruments

                13.2.1.1. Automated

                13.2.1.2. Semi-automated

                13.2.1.3. Manual

            13.2.2. Consumables

                13.2.2.1. Reagents

                13.2.2.2. Test Kits

                13.2.2.3. Antisera

                13.2.2.4. Others

            13.2.3. Services

        13.3. Market Attractiveness, by Product

        13.4. Market Value Forecast, by Technique, 2017–2031

            13.4.1. PCR-based

            13.4.2. Microarray-based

            13.4.3. Assay-based

            13.4.4. Massively Parallel

        13.5. Market Attractiveness, by Technique

        13.6. Market Value Forecast, by Test, 2017–2031

            13.6.1. Antibody Screening

            13.6.2. HLA Typing

            13.6.3. ABO Matching Test

            13.6.4. Cross Matching Test

            13.6.5. Antigen Typing

        13.7. Market Attractiveness, by Test

        13.8. Market Value Forecast, by End-user, 2017–2031

            13.8.1. Hospitals

            13.8.2. Clinical Laboratories

            13.8.3. Blood Banks

            13.8.4. Others

        13.9. Market Attractiveness, by End-user

        13.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.10.1. China

            13.10.2. Japan

            13.10.3. India

            13.10.4. Australia & New Zealand

            13.10.5. Rest of Asia Pacific

        13.11. Market Attractiveness Analysis

            13.11.1. By Product

            13.11.2. By Technique

            13.11.3. By Test

            13.11.4. By End-user

            13.11.5. By Country/Sub-region

    14. Latin America Blood Group Typing Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Product, 2017–2031

            14.2.1. Instruments

                14.2.1.1. Automated

                14.2.1.2. Semi-automated

                14.2.1.3. Manual

            14.2.2. Consumables

                14.2.2.1. Reagents

                14.2.2.2. Test Kits

                14.2.2.3. Antisera

                14.2.2.4. Others

            14.2.3. Services

        14.3. Market Attractiveness, by Product

        14.4. Market Value Forecast, by Technique, 2017–2031

            14.4.1. PCR-based

            14.4.2. Microarray-based

            14.4.3. Assay-based

            14.4.4. Massively Parallel

        14.5. Market Attractiveness, by Technique

        14.6. Market Value Forecast, by Test, 2017–2031

            14.6.1. Antibody Screening

            14.6.2. HLA Typing

            14.6.3. ABO Matching Test

            14.6.4. Cross Matching Test

            14.6.5. Antigen Typing

        14.7. Market Attractiveness, by Test

        14.8. Market Value Forecast, by End-user, 2017–2031

            14.8.1. Hospitals

            14.8.2. Clinical Laboratories

            14.8.3. Blood Banks

            14.8.4. Others

        14.9. Market Attractiveness, by End-user

        14.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.10.1. Brazil

            14.10.2. Mexico

            14.10.3. Rest of Latin America

        14.11. Market Attractiveness Analysis

            14.11.1. By Product

            14.11.2. By Technique

            14.11.3. By Test

            14.11.4. By End-user

            14.11.5. By Country/Sub-region

    15. Middle East & Africa Blood Group Typing Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Market Value Forecast, by Product, 2017–2031

            15.2.1. Instruments

                15.2.1.1. Automated

                15.2.1.2. Semi-automated

                15.2.1.3. Manual

            15.2.2. Consumables

                15.2.2.1. Reagents

                15.2.2.2. Test Kits

                15.2.2.3. Antisera

                15.2.2.4. Others

            15.2.3. Services

        15.3. Market Attractiveness, by Product

        15.4. Market Value Forecast, by Technique, 2017–2031

            15.4.1. PCR-based

            15.4.2. Microarray-based

            15.4.3. Assay-based

            15.4.4. Massively Parallel

        15.5. Market Attractiveness, by Technique

        15.6. Market Value Forecast, by Test, 2017–2031

            15.6.1. Antibody Screening

            15.6.2. HLA Typing

            15.6.3. ABO Matching Test

            15.6.4. Cross Matching Test

            15.6.5. Antigen Typing

        15.7. Market Attractiveness, by Test

        15.8. Market Value Forecast, by End-user, 2017–2031

            15.8.1. Hospitals

            15.8.2. Clinical Laboratories

            15.8.3. Blood Banks

            15.8.4. Others

        15.9. Market Attractiveness, by End-user

        15.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            15.10.1. GCC Countries

            15.10.2. South Africa

            15.10.3. Rest of Middle East & Africa

        15.11. Market Attractiveness Analysis

            15.11.1. By Product

            15.11.2. By Technique

            15.11.3. By Test

            15.11.4. By End-user

            15.11.5. By Country/Sub-region

    16. Competition Landscape

        16.1. Market Player – Competition Matrix (By Tier and Size of Companies)

        16.2. Market Share Analysis, by Company (2022)

        16.3. Company Profiles

            16.3.1. Grifols, S.A.

                16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.1.2. Product Portfolio

                16.3.1.3. Financial Overview

                16.3.1.4. SWOT Analysis

                16.3.1.5. Strategic Overview

            16.3.2. Bio-Rad Laboratories, Inc.

                16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.2.2. Product Portfolio

                16.3.2.3. Financial Overview

                16.3.2.4. SWOT Analysis

                16.3.2.5. Strategic Overview

            16.3.3. Merck KGaA

                16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.3.2. Product Portfolio

                16.3.3.3. Financial Overview

                16.3.3.4. SWOT Analysis

                16.3.3.5. Strategic Overview

            16.3.4. Ortho Clinical Diagnostics

                16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.4.2. Product Portfolio

                16.3.4.3. Financial Overview

                16.3.4.4. SWOT Analysis

                16.3.4.5. Strategic Overview

            16.3.5. AliveDx

                16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.5.2. Product Portfolio

                16.3.5.3. Financial Overview

                16.3.5.4. SWOT Analysis

                16.3.5.5. Strategic Overview

            16.3.6. ABG Health Care GmbH

                16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.6.2. Product Portfolio

                16.3.6.3. Financial Overview

                16.3.6.4. SWOT Analysis

                16.3.6.5. Strategic Overview

            16.3.7. Immucor, Inc.

                16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.7.2. Product Portfolio

                16.3.7.3. Financial Overview

                16.3.7.4. SWOT Analysis

                16.3.7.5. Strategic Overview

            16.3.8. Danaher Corporation

                16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.8.2. Product Portfolio

                16.3.8.3. Financial Overview

                16.3.8.4. SWOT Analysis

                16.3.8.5. Strategic Overview

            16.3.9. Agena Bioscience, Inc.

                16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.9.2. Product Portfolio

                16.3.9.3. Financial Overview

                16.3.9.4. SWOT Analysis

                16.3.9.5. Strategic Overview

            16.3.10. Rapid Labs Ltd.

                16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.10.2. Product Portfolio

                16.3.10.3. Financial Overview

                16.3.10.4. SWOT Analysis

                16.3.10.5. Strategic Overview

            16.3.11. Novacyt Group

                16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.11.2. Product Portfolio

                16.3.11.3. Financial Overview

                16.3.11.4. SWOT Analysis

                16.3.11.5. Strategic Overview

    List of Tables

    Table 01: Global Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017–2031

    Table 02: Global Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017–2031

    Table 03: Global Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 04: Global Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017–2031

    Table 05: Global Blood Group Typing Market Size (US$ Mn) Forecast, by Region, 2017–2031

    Table 06: North America Blood Group Typing Market Size (US$ Mn) Forecast, by Country, 2017–2031

    Table 07: North America Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017–2031

    Table 08: North America Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017–2031

    Table 09: North America Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017–2031

    Table 10: North America Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 11: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 12: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017–2031

    Table 13: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017–2031

    Table 14: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017–2031

    Table 15: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 16: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 17: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017–2031

    Table 18: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017–2031

    Table 19: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017–2031

    Table 20: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 21: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017–2031

    Table 23: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017–2031

    Table 24: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017–2031

    Table 25: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 26: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 27: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017–2031

    Table 28: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017–2031

    Table 29: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017–2031

    Table 30: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figures

    Figure 01: Global Blood Group Typing Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031

    Figure 02: Global Blood Group Typing Market Revenue (US$ Mn), by Product, 2022

    Figure 03: Global Blood Group Typing Market Value Share, by Product, 2022

    Figure 04: Global Blood Group Typing Market Revenue (US$ Mn), by Technique, 2022

    Figure 05: Global Blood Group Typing Market Value Share, by Technique, 2022

    Figure 06: Global Blood Group Typing Market Revenue (US$ Mn), by Test, 2022

    Figure 07: Global Blood Group Typing Market Value Share, by Test, 2022

    Figure 08: Global Blood Group Typing Market Revenue (US$ Mn), by End-user, 2022

    Figure 09: Global Blood Group Typing Market Value Share, by End-user, 2022

    Figure 10: Global Blood Group Typing Market Value Share, by Region, 2022

    Figure 11: Global Blood Group Typing Market Value (US$ Mn) Forecast, 2017–2031

    Figure 12: Global Blood Group Typing Market Value Share Analysis, by Product, 2022–2031

    Figure 13: Global Blood Group Typing Market Attractiveness Analysis, by Product, 2023–2031

    Figure 14: Global Blood Group Typing Market Value Share Analysis, by Technique, 2022–2031

    Figure 15: Global Blood Group Typing Market Attractiveness Analysis, by Technique, 2023–2031

    Figure 16: Global Blood Group Typing Market Value Share Analysis, by Test, 2022–2031

    Figure 17: Global Blood Group Typing Market Attractiveness Analysis, by Test, 2023–2031

    Figure 18: Global Blood Group Typing Market Revenue (US$ Mn), by End-user, 2022

    Figure 19: Global Blood Group Typing Market Value Share, by End-user, 2022

    Figure 20: Global Blood Group Typing Market Value Share Analysis, by Region, 2022–2031

    Figure 21: Global Blood Group Typing Market Attractiveness Analysis, by Region, 2023–2031

    Figure 22: North America Blood Group Typing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 23: North America Blood Group Typing Market Attractiveness Analysis, by Country, 2023–2031

    Figure 24: North America Blood Group Typing Market Value Share Analysis, by Country, 2022–2031

    Figure 25: North America Blood Group Typing Market Value Share Analysis, by Product, 2022–2031

    Figure 26: North America Blood Group Typing Market Value Share Analysis, by Technique, 2022–2031

    Figure 27: North America Blood Group Typing Market Value Share Analysis, by Test, 2022–2031

    Figure 28: North America Blood Group Typing Market Value Share Analysis, by End-user, 2022–2031

    Figure 29: North America Blood Group Typing Market Value Share Analysis, by End-user, 2022–2031

    Figure 30: North America Blood Group Typing Market Attractiveness Analysis, by Product, 2023–2031

    Figure 31: North America Blood Group Typing Market Attractiveness Analysis, by Technique, 2023–2031

    Figure 32: North America Blood Group Typing Market Attractiveness Analysis, by Test, 2023–2031

    Figure 33: North America Blood Group Typing Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 34: Europe Blood Group Typing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 35: Europe Blood Group Typing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 36: Europe Blood Group Typing Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 37: Europe Blood Group Typing Market Value Share Analysis, by Product, 2022–2031

    Figure 38: Europe Blood Group Typing Market Value Share Analysis, by Technique, 2022–2031

    Figure 39: Europe Blood Group Typing Market Value Share Analysis, by Test, 2022–2031

    Figure 40: Europe Blood Group Typing Market Value Share Analysis, by End-user, 2022–2031

    Figure 41: Europe Blood Group Typing Market Value Share Analysis, by End-user, 2022–2031

    Figure 42: Europe Blood Group Typing Market Attractiveness Analysis, by Product, 2023–2031

    Figure 43: Europe Blood Group Typing Market Attractiveness Analysis, by Technique, 2023–2031

    Figure 44: Europe Blood Group Typing Market Attractiveness Analysis, by Test, 2023–2031

    Figure 45: Europe Blood Group Typing Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 46: Asia Pacific Blood Group Typing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 47: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 48: Asia Pacific Blood Group Typing Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 50: Asia Pacific Blood Group Typing Market Value Share Analysis, by Product, 2022–2031

    Figure 51: Asia Pacific Blood Group Typing Market Value Share Analysis, by Technique, 2022–2031

    Figure 52: Asia Pacific Blood Group Typing Market Value Share Analysis, by Test, 2022–2031

    Figure 53: Asia Pacific Blood Group Typing Market Value Share Analysis, by End-user, 2022–2031

    Figure 54: Asia Pacific Blood Group Typing Market Value Share Analysis, by End-user, 2022–2031

    Figure 55: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by Product, 2023–2031

    Figure 56: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by Technique, 2023–2031

    Figure 57: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by Test, 2023–2031

    Figure 68: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 59: Latin America Blood Group Typing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 60: Latin America Blood Group Typing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 61: Latin America Blood Group Typing Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 62: Latin America Blood Group Typing Market Value Share Analysis, by Product, 2022–2031

    Figure 63: Latin America Blood Group Typing Market Value Share Analysis, by Technique, 2022–2031

    Figure 64: Latin America Blood Group Typing Market Value Share Analysis, by Test, 2022–2031

    Figure 65: Latin America Blood Group Typing Market Value Share Analysis, by End-user, 2022–2031

    Figure 66: Latin America Blood Group Typing Market Value Share Analysis, by End-user, 2022–2031

    Figure 67: Latin America Blood Group Typing Market Attractiveness Analysis, by Product, 2023–2031

    Figure 68: Latin America Blood Group Typing Market Attractiveness Analysis, by Technique, 2023–2031

    Figure 69: Latin America Blood Group Typing Market Attractiveness Analysis, by Test, 2023–2031

    Figure 70: Latin America Blood Group Typing Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 71: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 72: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 73: Middle East & Africa Blood Group Typing Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 74: Middle East & Africa Blood Group Typing Market Value Share Analysis, by Product, 2022–2031

    Figure 75: Middle East & Africa Blood Group Typing Market Value Share Analysis, by Technique, 2022–2031

    Figure 76: Middle East & Africa Blood Group Typing Market Value Share Analysis, by Test, 2022–2031

    Figure 77: Middle East & Africa Blood Group Typing Market Value Share Analysis, by End-user, 2022–2031

    Figure 78: Middle East & Africa Blood Group Typing Market Value Share Analysis, by End-user, 2022–2031

    Figure 79: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by Product, 2023–2031

    Figure 80: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by Technique, 2023–2031

    Figure 81: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by Test, 2023–2031

    Figure 82: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by End-user, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved